NEW YORK (GenomeWeb) – Alere today filed its financial results for the third quarter of 2016, reporting a 4 percent decrease in revenues year over year.

The filing puts the firm back on track with the timing of quarterly earnings reports filed with the US Securities and Exchange Commission. But Alere's results missed analyst revenue and EPS forecasts and its shares tumbled 13 percent in early afternoon trading on the New York Stock Exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.